Clinical Trials Logo
  1. Home
  2. Other
  3. NCT05075590

Coronary Access After Supra-Annular THV Implantation — CAN-ACCESS  

Transcatheter Aortic Valve Replacement Clinical Trial

Official title:
Coronary ANgiography and ACCESS Following Implantation of a Supra-Annular Transcatheter Heart Valve With Commissural Alignment: The CAN-ACCESS Pilot Study

Clinical Trial Summary

To determine the optimal technique and equipment for selective coronary engagement specifically following Evolut THV implantation using commissural alignment.

Clinical Trial Description

Patients will undergo elective transfemoral TAVR with the Evolut THV. The operators will attempt to selectively engage both the right and left coronary arteries through standardized angiographic views. The CCI-CIC CoreLabs will adjudicate angiographic views, post-TAVR CT scan, and determine if the coronaries were selectively engaged. Catheter choice, adjunctive tools if needed (e.g guide extension, wires etc) and engagement technique will be at the discretion of the operator. All images and fluoroscopic views will be anonymized, saved and imported to the CCI-CIC Angiographic and CT CoreLabs. Statistical analysis: Patient baseline and outcome data will be presented as mean and standard deviation (SD) for normally distributed variables, median and interquartile range (IQR) for non-normally distributed variables, and frequency and proportion for categorical variables. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05075590
Study type Interventional
Source University of British Columbia
Contact Pavneet Grewal
Phone 604-875-4111
Email pgrewal@cci-cic.org
Status Recruiting
Phase N/A
Start date October 27, 2021
Completion date July 31, 2024
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05465655 - Cara CDRM (Conduction Disturbance Risk Monitor) 2.0 N/A
Recruiting NCT04870424 - Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement Phase 3
Completed NCT02758964 - Evaluation of Cerebral Thrombembolism After TAVR
Recruiting NCT05758701 - CT TAVR Abdomen Study Phase 4
Active, not recruiting NCT04281771 - Assessment of Paravalvular Leak After TAVI by Hemodynamic Measurements and Cardiac MRI N/A
Enrolling by invitation NCT06212050 - Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis
Recruiting NCT04573049 - The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve Replacement Phase 4
Recruiting NCT05235555 - EffecTAVI Registry
Completed NCT05082337 - The SAVVY Guidewire in Transcatheter Aortic Valve Replacement Procedures N/A
Completed NCT01627691 - REPRISE II: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve System N/A
Completed NCT01651780 - Open-label, Randomized Trial in Patients Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH Phase 3
Recruiting NCT05259241 - ADAPT Transcatheter Aortic Valve Intervention (TAVI & Chronic Total Occlusion Percutaneous Coronary Intervention (CTO PCI) N/A
Completed NCT04489914 - Observational Study on the Application of High-Flow Therapy After Percutaneous Transfemoral Aortic Valve Replacement
Recruiting NCT03649594 - Risk Stratification Post TAVI Using TEG
Completed NCT04659538 - The CAPTIS® Study - Embolic Protection in TAVR N/A
Recruiting NCT04107038 - Monitored Anesthesia Care vs. General Anesthesia for Transcatheter Aortic Valve Replacement N/A
Withdrawn NCT04268160 - GPx Activity in Subjects With Aortic Stenosis Undergoing TAVR
Recruiting NCT02812953 - Biological Collection and Registry of Patients Who Will Have a TAVR (Transcatheter Aortic Valve Replacement) Intervention
Recruiting NCT05217888 - The Sentinel Registry
Recruiting NCT04982406 - Transcatheter Aortic Valve Replacement (TAVR) Effects on Cardiac Conduction System